Dexxos Participações (DEXP3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
27 Aug, 2026Executive summary
Net revenue for 1H24 was R$826.8 million, down 9.3% year-over-year, with adjusted net income of R$70.6 million, down 18.4% year-over-year, and adjusted EBITDA of R$133.6 million, down 21.1%, with a margin of 16.2%.
Gross profit reached R$184.1 million, a 7.1% decrease year-over-year, but gross margin improved by 0.5 p.p. to 22.3%.
Cash exceeded debt by R$64.2 million at quarter-end, improving by R$104.6 million from 2Q23.
Dividend distribution of R$48 million related to 2023 was fully paid, with R$36 million paid in May 2024.
Completed incorporation of Apolo and GPC Química, now holding 100% of both subsidiaries.
Financial highlights
2Q24 net revenue was R$438.9 million, down 0.9% year-over-year but up 13.1% sequentially.
2Q24 adjusted EBITDA was R$55.9 million, down 26.4% year-over-year; margin at 12.7%.
2Q24 adjusted net income was R$30.1 million, down 26.4% year-over-year.
Gross margin for 1H24 was 22.3%, up 0.5 p.p. year-over-year.
Adjusted EBITDA margin for 1H24 was 16.2%, down 2.4 p.p. year-over-year.
Outlook and guidance
Ongoing investments in innovation and specialty chemicals, including R$35 million invested in the Araucária plant.
Management is studying a potential conversion of preferred shares to common shares.
Focus on operational efficiency and portfolio diversification in both chemicals and steel segments.
Latest events from Dexxos Participações
- Robust growth, expanded capacity, and strong ESG practices drive leadership in core markets.DEXP3
Corporate presentation - Chemicals growth drove strong revenue and profit, while steel margins and EBITDA declined year-over-year.DEXP3
Q3 2024 - Revenue up 3.7% to R$1.81B, but EBITDA and net income fell amid margin and steel segment pressure.DEXP3
Q4 2024 - Net revenue rose 55.5% year-over-year to R$603.2 million, with strong growth in both segments.DEXP3
Q1 2025 - Net revenue rose 45.2% and adjusted EBITDA 16.8% year-over-year, with leverage at 0.3x.DEXP3
Q2 2025 - Net revenue up 30% and net income up 11.5% in 9M25, with margins down but cash and investments strong.DEXP3
Q3 2025 - Revenue up 18% to R$2.14B, margins down, strong cash, and new investments executed.DEXP3
Q4 2025 - Sequential margin gains and strong cash offset year-over-year revenue declines.DEXP3
Q1 2026 - Margins and net income improved despite lower revenue, with strong cash and new investments.DEXP3
Q2 2026